Cahill Represents Underwriters in $1.5 Billion Initial Public Offering for Ortho Clinical Diagnostics Holdings plc
Cahill represented the underwriters in connection with the initial public offering of ordinary shares by Ortho Clinical Diagnostics Holdings plc, resulting in gross proceeds of approximately $1.5 billion. 87,400,000 ordinary shares were sold by Ortho Clinical Diagnostics in the all primary offering. Proceeds from the offering are intended to be used to redeem existing indebtedness, working capital and general corporate purposes. Ortho Clinical Diagnostics is a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions.